Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Dual Blockade of Epidermal Growth Factor Receptor and Insulin-like Growth Factor Receptor-1 Signaling in Metastatic Pancreatic Cancer: Phase Ib and Randomized Phase II Trial of Gemcitabine, Erlotinib, and Cixutumumab versus Gemcitabine Plus Erlotinib (SWO
Relevant for weight loss patients who also have gut issues or connective tissue problems that are limiting their training
Franco R, Panayiotidis MI, Cidlowski JA
It works slowly
US$ 26.45
US$ 28.29
US$ 24.39
US$ 21.62
US$ 25.94
US$ 26.29
US$ 24.96
